The retrospective cohort study included more than 130,000 people in the US. It reveals that the shingles vaccine (called ...

A recent study suggests that certain immunizations may unexpectedly protect against cognitive decline, potentially reducing ...

The FDA has approved a prefilled syringe option of Shingrix which will streamline administration of GSK’s herpes zoster ...

This new Shingrix vaccine presentation eliminates the need for reconstitution, simplifying the administration process for ...

The Food and Drug Administration (FDA) has approved a new prefilled syringe presentation of Shingrix (zoster vaccine recombinant, adjuvanted).

Patients with inflammatory arthritis would benefit from vaccination against herpes zoster, with the Shingrix vaccine showing a crude effectiveness of 50%.

Pharmaceutical Technology serves as the connection to bio manufacturing and development, featuring regulatory updates and ...

Recent developments in the health sector highlight diverse changes from drug pricing initiatives by Bristol Myers and Pfizer ...

The U.S. Food and Drug Administration approved a pre-filled syringe version of GSK's blockbuster shingles vaccine Shingrix, ...

The US Food and Drug Administration (FDA) has approved GSK's Shingrix vaccine (recombinant zoster vaccine or RZV) in a ...

The newly approved prefilled syringe version of Shingrix is expected to simplify administration and supports efforts to ...